• UCLA Health
  • myUCLAhealth
  • School of Medicine
CARE Center

AIDS Institute

CARE Center   |  

CARE Center
  • About Us
    • History
    • Awards & Accomplishments
    • Staff
    • Our Directors
    • Faculty
    • Donate
    • News & Events
  • Patient Care
    • Medical Care Coordination
  • Clinical Trials
    • Immune Modulators Studies
    • HIV Treatment Studies
    • Hepatitis Co-Infection Studies
    • Human Papillomavirus (HPV) Studies
    • Studies for Women
    • Lymphoma Studies
    • Kaposi's Sarcoma Studies
    • Non-AIDS Defining Cancer
    • HIV Prevention
    • Discussion Groups
    • FAQ
    • Testimonials
    • HIV Treatment Studies
    • Immune Modulators
    • Hepatitis Co-infection Studies
    • Anchor Study (HPV)
    • Studies for Women
    • Lymphoma Studies
    • Kaposi's Sarcoma Studies
    • Non-AIDS Defining Cancer
    • HIV Prevention
    • FAQ
    • Testimonials
  • Community
    • Community Advisory Board
    • Partner of the Month
    • Prevention CAB
  • Research
    • Network Support
    • Conferences
  • RSVP
  • Contact Us
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

AIDS Institute

CARE Center   |  

Clinical Trials

Clinical Trials

Clinical Trials

  • HIV Treatment Studies
    • A5359 Long-acting ART
  • Immune Modulators
    • A5370
    • A5377
    • A5369
    • Pennvax Study
  • Hepatitis Co-infection Studies
    • A5360 MINMON
  • Anchor Study (HPV)
  • Studies for Women
  • Lymphoma Studies
  • Kaposi's Sarcoma Studies
  • Non-AIDS Defining Cancer
  • HIV Prevention
    • PrEP for HIV Prevention
    • Team PrEP
  • FAQ
  • Testimonials
  • HIV Treatment Studies
  • Immune Modulators
  • Hepatitis Co-infection Studies
  • Anchor Study (HPV)
  • Studies for Women
  • Lymphoma Studies
  • Kaposi's Sarcoma Studies
  • Non-AIDS Defining Cancer
  • HIV Prevention
  • FAQ
  • Testimonials
  1. Home
  2. Clinical Trials
  3. Anchor Study (HPV)

Human Papillomavirus (HPV) Studies

Share this

ANCHOR Trial: HPV & Anal Cancer Prevention

There are over 100 types of human papillomavirus (HPV) that infect humans. Some of these types infect the anal and mouth areas. HPV infections in these areas can damage the skin. Rarely, these damaged areas can turn into cancer. There are tests that can find these damaged areas so that they can be treated and removed.

A recent article raises concerns about the risk of the sexually contracted infections in men, due to the large spike in the number of head and neck cancers linked to HPV over the last 20 years within this population, bringing the CARE Center's research on HPV in men to the forefront.

A quadrivalent HPV vaccine, Gardasil, prevents anal HPV infection in HIV infected men. "Quadrivalent" means that the vaccine is directed at four of the HPV types, specifically the types of HPV that have been linked with genital warts and cancer.

Anchor Study:This study is for people 35 years of age or older, have HIV infection, have never been vaccinated against HPV, have never treated before for anal HSIL and have never had cancer of the anus, vulva, vagina or cervix.

For more information about the UCLA CARE Center's clinical trials and research studies, please contact:
(310) 557-9062
CAREOutreach@mednet.ucla.edu

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Publications
  • Giving
  • Careers
  • Volunteer
  • Privacy Practices
  • Nondiscrimination
  • Emergency
  • Smoke-Free
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Report Broken Links
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth

Learn more about myUCLAhealth